Literature DB >> 1413354

Preoperative assessment of prostatic carcinoma by computerized tomography. Weaknesses and new perspectives.

C E Engeler1, N F Wasserman, G Zhang.   

Abstract

A retrospective study of five years' experience with fourth-generation computerized tomography (CT) scan was undertaken to assess the frequency of understaging in prostate cancer. A total of 160 patients with preoperative scans were surgically staged. In 10 patients, the operation was aborted after pelvic node dissection had revealed unsuspected metastatic involvement. Based on the histopathologic evidence of local tumor invasion, extension into seminal vesicles or pelvic lymph nodes, restaging was required in 78 percent of cases. Accuracy was 24 percent for capsular extension, 69 percent for seminal vesicle invasion, and 72 percent for lymphadenopathy. The poor yield of CT scan as a preoperative staging modality is demonstrated. Recent advances in the understanding and management of prostatic cancer require reassessing patient benefit and cost effectiveness of available imaging techniques, focusing on the problem of detecting nodal metastases, and predicting tumor spread to regional lymph nodes by accurately evaluating the primary neoplasm. We conclude that CT scan fails to demonstrate the required precision needed to evaluate local tumor spread; therefore, this goal must be pursued with newer imaging modalities.

Entities:  

Mesh:

Year:  1992        PMID: 1413354     DOI: 10.1016/0090-4295(92)90386-b

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

1.  68Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate Cancer.

Authors:  Maria Vinsensia; Peter L Chyoke; Boris Hadaschik; Tim Holland-Letz; Jan Moltz; Klaus Kopka; Isabel Rauscher; Walter Mier; Markus Schwaiger; Uwe Haberkorn; Tobias Mauer; Clemens Kratochwil; Matthias Eiber; Frederik L Giesel
Journal:  J Nucl Med       Date:  2017-06-21       Impact factor: 10.057

Review 2.  Optimal cost-effective staging evaluations in prostate cancer.

Authors:  Gregory L Lacy; Douglas W Soderdahl; Javier Hernandez
Journal:  Curr Urol Rep       Date:  2007-05       Impact factor: 3.092

Review 3.  Imaging of distant metastases of prostate cancer.

Authors:  Filippo Pesapane; Marcin Czarniecki; Matteo Basilio Suter; Baris Turkbey; Geert Villeirs
Journal:  Med Oncol       Date:  2018-09-14       Impact factor: 3.064

Review 4.  Unmet needs in the prediction and detection of metastases in prostate cancer.

Authors:  Oliver Sartor; Mario Eisenberger; Michael W Kattan; Bertrand Tombal; Frederic Lecouvet
Journal:  Oncologist       Date:  2013-05-06

5.  Local staging of prostate carcinoma with endorectal coil MRI: correlation with whole-mount radical prostatectomy specimens.

Authors:  C Bartolozzi; I Menchi; R Lencioni; S Serni; A Lapini; G Barbanti; A Bozza; A Amorosi; A Manganelli; M Carini
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

6.  The importance of pelvic lymph node dissection in men with clinically localized prostate cancer.

Authors:  Mohamad E Allaf; Alan W Partin; H Ballentine Carter
Journal:  Rev Urol       Date:  2006

Review 7.  Lymph node staging in prostate cancer.

Authors:  Sandeep Sankineni; Anna M Brown; Michele Fascelli; Yan Mee Law; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Curr Urol Rep       Date:  2015-05       Impact factor: 3.092

Review 8.  Imaging of prostate cancer.

Authors:  P L Choyke
Journal:  Abdom Imaging       Date:  1995 Nov-Dec

9.  PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer.

Authors:  Frederik L Giesel; H Fiedler; M Stefanova; F Sterzing; M Rius; K Kopka; J H Moltz; A Afshar-Oromieh; P L Choyke; U Haberkorn; C Kratochwil
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-11       Impact factor: 9.236

Review 10.  Sentinel lymph node imaging in urologic oncology.

Authors:  Sherif Mehralivand; Henk van der Poel; Alexander Winter; Peter L Choyke; Peter A Pinto; Baris Turkbey
Journal:  Transl Androl Urol       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.